Genelex Blog White House 2016 Precision Medicine Initiative Summit – Recap In January 2015, President Obama announced the Precision Medicine Initiative, or PMI. The PMI was originally portioned $215 million in the 2016 budget, with the aim to use patient volunteered data on a massive scale
U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs
Genelex Blog U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs The U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Genelex as a government supplier, which took effect March 15th, 2016. The contract makes pharmacogenetic testing
Precision Trials Challenge
Genelex Blog Precision Trials Challenge Big thanks to Ranjit who submitted to this challenge with little notice, description is below. Comments from the online community will also be used as judging criteria. So any responses via comments/applause/views via the link below with respect to
United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract
Genelex Blog United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract Pharmacogenetic testing now available to improve complex medication management for veterans at risk of avoidable hospitalizations and ER visits Seattle, WA—March 15, 2016 – Genelex, the
Visit Genelex this week at HIMSS16 in Las Vegas
Genelex Blog Visit Genelex this week at HIMSS16 in Las Vegas Visit Genelex this week at HIMSS16 in Las Vegas and see why we’re in the headlines: HIMSS Honoree explains why you won’t want to miss Genelex at the conference: “This is a real, practical application of precision medicine that
An Alternative to the Hype of the HIMSS16 Show Floor
Genelex Blog An Alternative to the Hype of the HIMSS16 Show Floor Dave Garets, Healthcare IT industry analyst I know what you’re thinking: “Garets is mouthing off again. Thank goodness he doesn’t do it more than once a year.” Last year about this time I blogged about what you’d see at
Oxycodone Toxicity
Genelex Blog Oxycodone Toxicity On April 7, 2015 we blogged about a young boy who became comatose after receiving tramadol for post-tonsillectomy pain treatment. It was later learned that the boy was a CYP2D6 ultra rapid metabolizer. Then on July 21, 2015, we blogged about the risks of
Tamoxifen and CYP2D6 Interactions
Genelex Blog Tamoxifen and CYP2D6 Interactions CYP2D6 gene testing for personalizing tamoxifen therapy has been a source of confusion and debate for over a decade. In addition to conflicting outcomes data on breast cancer recurrence rates in women with deficient CYP2D6 enzyme activity (i.e.,